12 November 2014 |
| 09:30-16:00 | | Registration
|
| 09:55-16:15 | | CME Training Day - please see separate programme for full information Please note: the CME Training Day is separate to the BSPED 2014 meeting and there are separate registrations fees to attend each
|
| 16:30-18:00 | | Industry Sponsored Satellite Symposia Chair(s): S Alvi (Leeds, UK) Supported by Lilly
|
| 16:30 - 17:15 | Sat Symp 1.1 | Understanding genetic imprinting |
| 17:15 - 18:00 | Sat Symp 1.2 | Russell Silver Syndrome: From clinical and molecular diagnosis to treatment |
| 18:00-19:15 | | Welcome Reception Guildhall Winchester
|
13 November 2014 |
| 08:00-16:00 | | Registration
|
| 08:30-09:00 | | Welcome Chair(s): J Davies (Southampton, UK)
|
| 09:00-10:30 | | Oral Communications 3: Paediatric Endocrinology Chair(s): T Cheetham (Newcastle, UK) & M Dattani (London, UK)
|
| 09:00 | OC3.1 | Scottish Audit Of Atypical Genitalia – First Year Results |
| 09:10 | OC3.2 | Vertebral Fracture Assessment In a Paediatric Population Using Dual-Energy X-ray Absorptiometry. |
| 09:20 | OC3.3 | An analysis of meta-data from three UK centres on the sequelae of paediatric craniopharyngiomas over four decades |
| 09:30 | OC3.4 | Standard Population Screening for Diabetes mellitus has low sensitivity in identifying diabetes in adult survivors of childhood bone marrow transplantation with total body irradiation |
| 09:40 | OC3.5 | Statistical prediction of HRpQCT microstructural trabecular parameters using 1.5T skeletal MRI |
| 09:50 | OC3.6 | A novel non-invasive Short Synacthen Test |
| 10:00 | OC3.7 | Patterns of gene expression in pre-pubertal children are associated with the severity of their growth hormone deficiency (GHD) |
| 10:10 | OC3.8 | Trends In Off-Label Prescription Of Growth Hormone: Results From The National GH Audit |
| 10:20 | OC3.9 | Physiological dose reverse rhythm testosterone treatment abolishes the development of permanent gynaecomastia in adolescents with 47,XXY Klinefelter |
| 09:10-09:45 | | Diabetes Professionals session 1 Chair(s): K Beddows (Stockport, UK) & C Gelder (York, UK)
|
| 09:10 | DP1 | Obesity in Children |
| 09:45-10:30 | | Diabetes Professionals session 2 Chair(s): K Beddows (Stockport, UK) & C Gelder (York, UK)
|
| 09:45 | DP2 | Type 2 diabetes |
| 10:30-11:00 | | Tea & Coffee
|
| 10:50-11:45 | | Diabetes Professionals session 3 Chair(s): K Beddows (Stockport, UK) & C Gelder (York, UK)
|
| 10:50 | DP3 | Hypoglycaemia |
| 11:00-12:30 | | Symposium 1: Controversies in vitamin D deficiency Chair(s): J Davies (Southampton, UK) & P Arundel (Sheffield, UK)
|
| 11:00 | S1.1 | Consequences of maternal vitamin D deficiency |
| 11:30 | S1.2 | The role of vitamin D deficiency in unexplained fracture of infancy |
| 12:00 | S1.3 | Strategies for prophylaxis and treatment of vitamin D deficiency |
| 11:45-12:30 | | Diabetes Professionals session 4 Chair(s): K Beddows (Stockport, UK) & C Gelder (York, UK)
|
| 11:45 | DP4 | Psychology |
| 12:30-14:00 | | RCN CYP AGM
|
| 12:30-14:00 | | Lunch, Exhibition and Poster Viewing
|
| 13:15-14:00 | | Guided Poster Tour
|
| 14:00-14:30 | | Diabetes Professionals session 5 Chair(s): G Parfit (Gwent, UK) & J Summerton (Southampton, UK)
|
| 14:00 | DP5 | School Care Plans |
| 14:00-15:00 | | Oral Communications 4: Paediatrtic Endocrinology Chair(s): J Warner (Cardiff, UK) & N Davis (Southampton, UK)
|
| 14:00 | OC4.1 | Utility of basal LH in comparison to the GnRH test for identifying central precocious puberty in girls. |
| 14:06 | OC4.2 | Validation of a Food Frequency Questionnaire (FFQ) for rapid assessment of daily dietary Calcium (Ca) intake in children |
| 14:12 | OC4.3 | A role for Delta-like homologue 1 (DLK1) in a secretory placental population and implications for fetal growthgrowthAbstract |
| 14:18 | OC4.4 | Expression of Sonic hedgehog signalling components in the developing human adrenal cortex. |
| 14:24 | OC4.5 | Adiposity differs by fracture site in children with upper limb fractures |
| 14:30 | OC4.6 | Evaluating dipeptidyl peptidase-4 expression in patients with diffuse and focal congenital hyperinsulinism. |
| 14:36 | OC4.7 | Pitfalls in the diagnosis of neonatal adrenal insufficiency |
| 14:42 | OC4.8 | Recombinant Human Growth Hormone (rhGH) In Paediatric Inflammatory Bowel Disease(IBD): Short Term Effects On Bone Biomarkers and Long Term Effects On Bone And Lean Mass |
| 14:48 | OC4.9 | Neurodevelopmental Phenotypes In Children with Early and Late Presenting Congenital Hyperinsulinism (CHI) |
| 14:54 | OC4.10 | Impact of prematurity on timing of puberty |
| 14:30-15:00 | | Diabetes Professionals session 6 Chair(s): G Parfit (Gwent, UK) & J Summerton (Southampton, UK)
|
| 14:30 | DP6 | Fat and Protein counting what's the evidence? |
| 15:00-15:30 | | Tea & Coffee
|
| 15:30-16:30 | | Diabetes Professionals session 7 Chair(s): G Parfit (Gwent, UK) & J Summerton (Southampton, UK)
|
| 15:30 | DP7 | Best Practice Tariff |
| 15:30-16:30 | | Symposium 2: Recent advances in adrenal disease Chair(s): N Krone (Birmingham, UK) & L Chan (London, UK)
|
| 15:30 | S2.1 | Adrenal Development and Adrenal Insufficiency |
| 16:00 | S2.2 | Curing Addisson's Disease |
| 16:45-18:00 | | BSPED AGM
|
| 19:30-00:00 | | Conference Dinner and Awards Ceremony Mercure Winchester Wessex Hotel
|
14 November 2014 |
| 07:30-16:00 | | Registration
|
| 08:00-09:00 | | Industry Sponsored Satellite Symposium Chair(s): C Acerini (Cambridge,UK) Supported by Ferring Pharmaceuticals
|
| 08:00 | Sat Symp 2.1 | Maintaining persistence and adherence with subcutaneous growth-hormone therapy in children: comparing Jet delivery and needle-based devices |
| 08:15 | sat Symp 2.2 | Title TBC |
| 08:30 | Sat Symp 2.3 | Patient choice: What does it really mean? |
| 08:45 | Sat Symp 2.4 | Panel discussion |
| 09:00-09:55 | | Endocrine Nurse's Business Meeting Chair(s): A Whitehead (Leeds, UK)
|
| 09:00-10:30 | | Symposium 3: New developments from trials in TIDM Chair(s): P Hindmarsh (London,UK) & F Campbell (Leeds,UK)
|
| 09:00 | S3.1 | Findings from the DECIDE trial |
| 09:30 | S3.2 | How do the findings from the Hvidore study change practice? |
| 10:00 | S3.3 | Prevention trials in type 1 diabetes’, including an update on the ongoing TRIGR trial |
| 09:55-10:00 | | Endocrine Nurse's Welcome Chair(s): S Kerr (Southampton, UK) & N Nicol (Bristol, UK)
|
| 10:00-10:30 | | Oral Communications 5: Endocrine Nurse session Chair(s): S Kerr (Southampton, UK) & N Nicol (Bristol,UK)
|
| 10:00 - 10:10 | OC5.1 | Congenital Adrenal Hyperplasia – a survey on the current practice in U.K |
| 10:10 - 10:20 | OC5.2 | The impact on families of receiving a diagnosis of congenital hypothyroidism |
| 10:20 - 10:30 | OC5.3 | Does treatment with gonadotropin releasing hormone (GnRH) analogues affect BMI in children with precocious or early puberty? |
| 10:30-11:00 | | Tea & Coffee
|
| 11:00-11:25 | | Endocrine Nurse session 1 Chair(s): S Kerr (Southampton, UK) & N Nicol (Bristol, UK)
|
| EN1 | Genetics – back to basics |
| 11:00-11:30 | | BSPED Research Award Winners Presentation from 2012 PLEASE NOTE: This session has been cancelled due to unforseen circumstances
|
| 11:30-11:55 | | Endocrine Nurse session 2 Chair(s): S Kerr (Southampton, UK) & N Nicol (Bristol, UK)
|
| EN2 | Breathe Easy –the significance of respiratory assessment in Prader-Willi Syndrome |
| 11:30-12:30 | | Oral Communications 6: Paediatric Diabetes Chair(s): J Edge (Oxford, UK) & N Trevelyan (Southampton, UK)
|
| 11:30 | OC6.1 | Exploring variation in treatment targets across paediatric diabetes units in England and Wales |
| 11:40 | OC6.2 | The diabetic pregnancy and offspring adiposity in infancy and childhood: a meta-analysis |
| 11:50 | OC6.3 | Comparison of breath acetone, with blood glucose and blood ketones in children and adolescents with type 1 diabetes |
| 12:00 | OC6.4 | The Role Of The AMP-K Pathway In Mediating The Effects Of Metformin On Mesenchymal Stem Cell Differentiation |
| 12:10 | OC6.5 | Withdrawn |
| 12:20 | OC6.6 | Comparison of Type 1 diabetic control before and 5 years after transfer to adult services : audit of the 2008 cohort from the Royal Hospital of Sick Children (RHSC), Glasgow |
| 11:55-12:10 | | Endocrine Nurse session 3 Chair(s): S Kerr (Southampton, UK) & N Nicol (Bristol, UK)
|
| EN3 | Sleep Easy – the practicalities of sleep study |
| 12:15-12:55 | | Endocrine Nurse session 4 Chair(s): S Kerr (Southampton, UK) & A Whitehead (Leeds, UK)
|
| EN4 | House Discussion: Hydrocortisone In schools - to teach or not to teach |
| 12:30-13:00 | | Oral Communications 7: Paediatric Diabetes Chair(s): J Edge (Oxford, UK) & N Trevelyan (Southampton, UK)
|
| 12:30 | OC7.1 | Additional professional support for paediatric patients with diabetes mellitus - are we targeting the right patients? |
| 12:36 | OC7.2 | Urinary vitamin E metabolites as a biomarker of oxidative stress in type 1 diabetes. |
| 12:42 | OC7.3 | Do diabetes teams give consistent advice on self-management and does it relate to glycaemic control? – Yorkshire and Humber Paediatric Diabetes network survey |
| 12:48 | OC7.4 | Hyperosmolar hyperglycaemic state –An unusual presentation of type 2 diabetes mellitus in children |
| 12:54 | OC7.5 | The relationship of Vibration Perception Threshold with metabolic control and duration of disease in British children with Type 1 Diabetes |
| 13:00-14:00 | | Lunch, Exhibition and Poster Viewing
|
| 14:00-14:45 | | Plenary guest lecture Chair(s): J Barton (Bristol, UK)
|
| 14:00 -14:45 | PL1 | The future of the child with T1DM |
| 14:45-15:45 | | Debate: Children with diabetes should be managed centrally Chair(s): J Walker (Portsmouth, UK)
|
| 14:45 | D1.2 | Against |
| 14:45 | D1.1 | For |
| 15:45-16:00 | | Close of meeting
|